Massingham R[au] - Search Results

Year	Number of Results
1968	1
1969	1
1970	1
1971	1
1972	1
1973	2
1974	1
1975	1
1977	3
1978	1
1979	2
1980	5
1981	4
1982	3
1983	2
1984	1
1985	3
1986	3
1988	1
1989	4
1990	1
1991	1
1992	4
1993	2
1994	1
1995	3
1997	2
1998	1
2000	1
2002	4
2003	4
2004	2
2005	3
2006	4
2007	2
2021	0

1

H1 antagonists: receptor affinity versus selectivity.

Gillard M, Christophe B, Wels B, Peck M, Massingham R, Chatelain P. Gillard M, et al. Among authors: massingham r. Inflamm Res. 2003 Apr;52 Suppl 1:S49-50. doi: 10.1007/s000110300050. Inflamm Res. 2003. PMID: 12755407 No abstract available.

2

Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.

Langer SZ, Cavero I, Massingham R. Langer SZ, et al. Among authors: massingham r. Hypertension. 1980 Jul-Aug;2(4):372-82. doi: 10.1161/01.hyp.2.4.372. Hypertension. 1980. PMID: 6105128 Review.

3

Peripheral receptor populations involved in the regulation of gastrointestinal motility and the pharmacological actions of metoclopramide-like drugs.

Fernández AG, Massingham R. Fernández AG, et al. Among authors: massingham r. Life Sci. 1985 Jan 7;36(1):1-14. doi: 10.1016/0024-3205(85)90280-2. Life Sci. 1985. PMID: 2981378 Review.

4

Paracetamol potentiates isaxonine toxicity in vitro.

Shrivastava R, John G, Chevalier A, Beaughard M, Rispat G, Slaoui M, Massingham R. Shrivastava R, et al. Among authors: massingham r. Toxicol Lett. 1994 Sep;73(3):167-73. doi: 10.1016/0378-4274(94)90055-8. Toxicol Lett. 1994. PMID: 8091425

5

Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

Cambridge D, Davey MJ, Massingham R. Cambridge D, et al. Among authors: massingham r. Br J Pharmacol. 1977 Mar;59(3):514P-515P. Br J Pharmacol. 1977. PMID: 14760 Free PMC article. No abstract available.

6

Bepridil: a pharmacological reappraisal of its potential beneficial effects in angina and tissue protection following ischemia.

Massingham R, Van Zwieten PA. Massingham R, et al. Cardiovasc Drugs Ther. 1989 Oct;3(5):731-42. doi: 10.1007/BF01857623. Cardiovasc Drugs Ther. 1989. PMID: 2488109 Review.

7

Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part I: Subclassification and functional description.

Cavero I, Massingham R, Lefèvre-Borg F. Cavero I, et al. Among authors: massingham r. Life Sci. 1982 Sep 6;31(10):939-48. doi: 10.1016/0024-3205(82)90165-5. Life Sci. 1982. PMID: 6752615 Review.

8

The histamine H(1)-receptor antagonist cetirizine does not interact with bradykinin B(1) or B(2)-receptors in vitro.

Christophe B, Maleux MR, Gillard M, Chatelain P, Peck MJ, Massingham R. Christophe B, et al. Among authors: massingham r. Inflamm Res. 2004 Mar;53 Suppl 1:S81-2. doi: 10.1007/s00011-003-0339-9. Epub 2004 Mar 5. Inflamm Res. 2004. PMID: 15054630 No abstract available.

9

Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents. Part II: Sites and mechanisms of action of dopamine receptor agonists.

Cavero I, Massingham R, Lefèvere-Borg F. Cavero I, et al. Among authors: massingham r. Life Sci. 1982 Sep 13;31(11):1059-69. doi: 10.1016/0024-3205(82)90078-9. Life Sci. 1982. PMID: 6755118 Review.

10

Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.

Langer SZ, Duval N, Massingham R. Langer SZ, et al. Among authors: massingham r. J Cardiovasc Pharmacol. 1985;7 Suppl 8:S1-8. J Cardiovasc Pharmacol. 1985. PMID: 2417042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results